Insider · CIK 0001413748

Friedman Charlene A

Reports to the SEC for 1 company · MOUNTAIN VIEW, CA

sec.gov

Transactions

Companies

Filings

CIK

0001413748

Forms 4 and 5

Insider transactions

43 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2013-03-01	MAP Pharmaceuticals, Inc.Restricted Stock Unit (RSU)D Disposition to Issuer	SVP, Gen Counsel & Sec	DDisposition to Issuer	−4,500 sh	—	—	0
2013-03-01	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	SVP, Gen Counsel & Sec	DDisposition to Issuer	−30K sh	—	—	0
2013-03-01	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	SVP, Gen Counsel & Sec	DDisposition to Issuer	−50.8K sh	—	—	0
2013-03-01	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	SVP, Gen Counsel & Sec	DDisposition to Issuer	−55K sh	—	—	0
2013-03-01	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	SVP, Gen Counsel & Sec	DDisposition to Issuer	−27.5K sh	—	—	0
2013-03-01	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	SVP, Gen Counsel & Sec	DDisposition to Issuer	−32.5K sh	—	—	0
2013-03-01	MAP Pharmaceuticals, Inc.Restricted Stock Unit (RSU)D Disposition to Issuer	SVP, Gen Counsel & Sec	DDisposition to Issuer	−8,250 sh	—	—	0
2013-03-01	MAP Pharmaceuticals, Inc.U Disposition from Tender	SVP, Gen Counsel & Sec	UDisposition from Tender	−4,229 sh	$25.00	−$106K	0
2013-03-01	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	SVP, Gen Counsel & Sec	DDisposition to Issuer	−74.7K sh	—	—	0
2013-01-26	MAP Pharmaceuticals, Inc.M Exercise/Conversion	SVP, Gen Counsel & Sec	MExercise/Conversion	+2,250 sh	—	—	5,100
2013-01-26	MAP Pharmaceuticals, Inc.F Tax Payment	SVP, Gen Counsel & Sec	FTax Payment	−871 sh	$24.75	−$21.6K	4,229
2013-01-26	MAP Pharmaceuticals, Inc.Common StockM Exercise/Conversion	SVP, Gen Counsel & Sec	MExercise/Conversion	−2,250 sh	—	—	4,500
2013-01-25	MAP Pharmaceuticals, Inc.M Exercise/Conversion	SVP, Gen Counsel & Sec	MExercise/Conversion	+2,750 sh	—	—	4,057
2013-01-25	MAP Pharmaceuticals, Inc.F Tax Payment	SVP, Gen Counsel & Sec	FTax Payment	−1,207 sh	$24.75	−$29.9K	2,850
2013-01-25	MAP Pharmaceuticals, Inc.Common StockM Exercise/Conversion	SVP, Gen Counsel & Sec	MExercise/Conversion	−2,750 sh	—	—	8,250
2012-03-09	MAP Pharmaceuticals, Inc.S Sale	SVP, Gen Counsel & Sec	SSale	−10K sh	$17.50	−$175K	1,307
2012-03-09	MAP Pharmaceuticals, Inc.M Exercise/Conversion	SVP, Gen Counsel & Sec	MExercise/Conversion	+10K sh	$12.37	+$124K	11,307
2012-03-09	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)M Exercise/Conversion	SVP, Gen Counsel & Sec	MExercise/Conversion	−10K sh	—	—	22,328
2012-01-26	MAP Pharmaceuticals, Inc.F Tax Payment	SVP, Gen Counsel & Sec	FTax Payment	−943 sh	$13.84	−$13.1K	1,307
2012-01-26	MAP Pharmaceuticals, Inc.Restricted Stock Unit (RSU)M Exercise/Conversion	SVP, Gen Counsel & Sec	MExercise/Conversion	−2,250 sh	—	—	6,750
2012-01-26	MAP Pharmaceuticals, Inc.M Exercise/Conversion	SVP, Gen Counsel & Sec	MExercise/Conversion	+2,250 sh	—	—	2,250
2012-01-25	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	SVP, Gen Counsel & Sec	AAward	+32.5K sh	—	—	32,500
2012-01-25	MAP Pharmaceuticals, Inc.Restricted Stock Unit (RSU)A Award	SVP, Gen Counsel & Sec	AAward	+11K sh	—	—	11,000
2011-01-26	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	SVP, Gen Counsel & Sec	AAward	+27.5K sh	—	—	27,500
2011-01-26	MAP Pharmaceuticals, Inc.Restricted Stock Unit (RSU)A Award	SVP, Gen Counsel & Sec	AAward	+9,000 sh	—	—	9,000
2010-12-20	MAP Pharmaceuticals, Inc.Stock OptionM Exercise/Conversion	SVP, Gen Counsel & Sec	MExercise/Conversion	−3,120 sh	—	—	38,828
2010-12-20	MAP Pharmaceuticals, Inc.M Exercise/Conversion	SVP, Gen Counsel & Sec	MExercise/Conversion	+3,120 sh	$10.37	+$32.4K	3,120
2010-12-20	MAP Pharmaceuticals, Inc.S Sale	SVP, Gen Counsel & Sec	SSale	−3,120 sh	$15.50	−$48.4K	0
2010-10-27	MAP Pharmaceuticals, Inc.S Sale	SVP, Gen Counsel & Sec	SSale	−7,800 sh	$15.53	−$121K	0
2010-10-27	MAP Pharmaceuticals, Inc.M Exercise/Conversion	SVP, Gen Counsel & Sec	MExercise/Conversion	+7,800 sh	$10.37	+$80.9K	7,800
2010-10-27	MAP Pharmaceuticals, Inc.Stock OptionM Exercise/Conversion	SVP, Gen Counsel & Sec	MExercise/Conversion	−7,800 sh	—	—	41,948
2010-05-13	MAP Pharmaceuticals, Inc.Stock OptionM Exercise/Conversion	SVP, Gen Counsel & Sec	MExercise/Conversion	−1,560 sh	—	—	49,748
2010-05-13	MAP Pharmaceuticals, Inc.S Sale	SVP, Gen Counsel & Sec	SSale	−1,560 sh	$17.07	−$26.6K	0
2010-05-13	MAP Pharmaceuticals, Inc.M Exercise/Conversion	SVP, Gen Counsel & Sec	MExercise/Conversion	+1,560 sh	$10.37	+$16.2K	1,560
2010-04-26	MAP Pharmaceuticals, Inc.Stock OptionM Exercise/Conversion	SVP, Gen Counsel & Sec	MExercise/Conversion	−10.2K sh	—	—	51,308
2010-04-26	MAP Pharmaceuticals, Inc.M Exercise/Conversion	SVP, Gen Counsel & Sec	MExercise/Conversion	+10.2K sh	$10.37	+$105K	10,155
2010-04-26	MAP Pharmaceuticals, Inc.S Sale	SVP, Gen Counsel & Sec	SSale	−10.2K sh	$18.03	−$183K	0
2010-04-14	MAP Pharmaceuticals, Inc.M Exercise/Conversion	SVP, Gen Counsel & Sec	MExercise/Conversion	+1,560 sh	$10.37	+$16.2K	1,560
2010-04-14	MAP Pharmaceuticals, Inc.Stock OptionM Exercise/Conversion	SVP, Gen Counsel & Sec	MExercise/Conversion	−1,560 sh	—	—	61,463
2010-04-14	MAP Pharmaceuticals, Inc.S Sale	SVP, Gen Counsel & Sec	SSale	−1,560 sh	$16.05	−$25K	0
2010-02-02	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	SVP, Gen Counsel & Sec	AAward	+55K sh	—	—	55,000
2009-02-11	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	SVP, Gen Counsel & Sec	AAward	+75K sh	$10.37	+$778K	75,000
2008-01-22	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	SVP, Gen Counsel & Sec	AAward	+30K sh	$13.12	+$394K	30,000

Recent filings

Accepted (ET)
Mar 44
Friedman Charlene A0001181431-13-014240
SEC(opens sec.gov)
Jan 294
Friedman Charlene A0001181431-13-005436
SEC(opens sec.gov)
Mar 134
Friedman Charlene A0001181431-12-016909
SEC(opens sec.gov)
Jan 274
Friedman Charlene A0001181431-12-004333
SEC(opens sec.gov)

Companies

MAP Pharmaceuticals, Inc.SVP, Gen Counsel & Sec

Address

C/O MAP PHARMACEUTICALS, INC. 2400 BAYSHORE PARKWAY, SUITE 200

MOUNTAIN VIEW, CA, 94043